DE60229046D1 - Chinazolin derivate - Google Patents
Chinazolin derivateInfo
- Publication number
- DE60229046D1 DE60229046D1 DE60229046T DE60229046T DE60229046D1 DE 60229046 D1 DE60229046 D1 DE 60229046D1 DE 60229046 T DE60229046 T DE 60229046T DE 60229046 T DE60229046 T DE 60229046T DE 60229046 D1 DE60229046 D1 DE 60229046D1
- Authority
- DE
- Germany
- Prior art keywords
- sup
- formula
- derivatives
- containment
- chinazoline derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01401007 | 2001-04-19 | ||
PCT/GB2002/001734 WO2002085895A1 (en) | 2001-04-19 | 2002-04-15 | Quinazoline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60229046D1 true DE60229046D1 (de) | 2008-11-06 |
Family
ID=8182691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60229046T Expired - Lifetime DE60229046D1 (de) | 2001-04-19 | 2002-04-15 | Chinazolin derivate |
Country Status (7)
Country | Link |
---|---|
US (1) | US7141577B2 (de) |
EP (1) | EP1381599B1 (de) |
JP (1) | JP4307843B2 (de) |
AT (1) | ATE409185T1 (de) |
DE (1) | DE60229046D1 (de) |
ES (1) | ES2312557T3 (de) |
WO (1) | WO2002085895A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100821446B1 (ko) | 2000-08-21 | 2008-04-10 | 아스트라제네카 아베 | 퀴나졸린 유도체 |
JP2004511479A (ja) | 2000-10-13 | 2004-04-15 | アストラゼネカ アクチボラグ | キナゾリン誘導体 |
US6939866B2 (en) | 2000-10-13 | 2005-09-06 | Astrazeneca Ab | Quinazoline derivatives |
JP4564713B2 (ja) | 2000-11-01 | 2010-10-20 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | 窒素性複素環式化合物、ならびに窒素性複素環式化合物およびその中間体を作製するための方法 |
ES2312557T3 (es) | 2001-04-19 | 2009-03-01 | Astrazeneca Ab | Derivados de quinazolina. |
DE60215178T2 (de) | 2001-07-16 | 2007-08-23 | Astrazeneca Ab | Quinolin-derivate und ihre verwendung als inhibitoren der tyrosine kinase |
GB0128122D0 (en) | 2001-11-23 | 2002-01-16 | Astrazeneca Ab | Therapeutic use |
ATE429230T1 (de) | 2002-07-09 | 2009-05-15 | Astrazeneca Ab | Chinazoline derivative und ihre anwendung in der krebsbehandlung |
GB0215823D0 (en) | 2002-07-09 | 2002-08-14 | Astrazeneca Ab | Quinazoline derivatives |
US7576074B2 (en) | 2002-07-15 | 2009-08-18 | Rice Kenneth D | Receptor-type kinase modulators and methods of use |
GB0225579D0 (en) | 2002-11-02 | 2002-12-11 | Astrazeneca Ab | Chemical compounds |
BR0315756A (pt) * | 2002-11-04 | 2005-09-06 | Astrazeneca Ab | Derivado de quinazolina ou um seu sal farmaceuticamente aceitável, processo para a preparação do mesmo, composição farmacêutica, uso do dito derivado ou de um seu sal farmaceuticamente aceitável, e, método para produzir um efeito anti-invasivo pela detenção e/ou pelo tratamento de doença de tumor sólido em um animal de sangue quente necessitando de tal tratamento |
WO2005030140A2 (en) | 2003-09-26 | 2005-04-07 | Exelixis, Inc. | C-met modulators and methods of use |
GB0427697D0 (en) | 2004-12-17 | 2005-01-19 | Astrazeneca Ab | Chemical process |
EP2387563B2 (de) | 2009-01-16 | 2022-04-27 | Exelixis, Inc. | Malatsalz von n-(4-{[6,7-bis(methyloxy)chinolin-4-yl]-oxy}phenyl-n'-(4-fluorphenyl)cyclo-propan-1,1-dicarbonsäureamid und kristalline formen davon zur behandlung von krebs |
UA108618C2 (uk) | 2009-08-07 | 2015-05-25 | Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку | |
US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
EP3763710A1 (de) | 2013-02-20 | 2021-01-13 | Kala Pharmaceuticals, Inc. | Therapeutische verbindungen und verwendungen davon |
US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
CN108064274A (zh) | 2014-07-30 | 2018-05-22 | 耶达研究及发展有限公司 | 用于培养多能干细胞的培养基 |
BR112018006873A2 (pt) | 2015-10-05 | 2018-11-06 | The Trustees Of Columbia University In The City Of New York | ativadores do fluxo autofágico e fosfolipase d e depuração de agregados de proteína incluindo tau e tratamento de proteinopatias |
AU2019255310B2 (en) | 2018-04-18 | 2022-11-24 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
US11919912B2 (en) | 2018-05-21 | 2024-03-05 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
EP3914698A1 (de) | 2019-01-23 | 2021-12-01 | Yeda Research and Development Co. Ltd | Kulturmedien für pluripotente stammzellen |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL89029A (en) | 1988-01-29 | 1993-01-31 | Lilly Co Eli | Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them |
US5411963A (en) * | 1988-01-29 | 1995-05-02 | Dowelanco | Quinazoline derivatives |
IL89028A0 (en) * | 1988-01-29 | 1989-08-15 | Lilly Co Eli | Quinoline,quinazoline and cinnoline derivatives |
US5710158A (en) | 1991-05-10 | 1998-01-20 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
EP0584222B1 (de) | 1991-05-10 | 1997-10-08 | Rhone-Poulenc Rorer International (Holdings) Inc. | Bis mono- und bicyclische aryl- und heteroarylderivate mit inhibierender wirkung auf die egf und/oder pdgf-rezeptor tyrosinkinase |
US5721237A (en) | 1991-05-10 | 1998-02-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
PT100905A (pt) * | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
GB9323290D0 (en) | 1992-12-10 | 1994-01-05 | Zeneca Ltd | Quinazoline derivatives |
IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
KR100225721B1 (ko) | 1994-02-23 | 1999-10-15 | 디. 제이. 우드, 스피겔 알렌 제이 | 4-헤테로사이클릴-치환된 퀴나졸린 유도체, 이들의 제조 방법 및항암제로서의 용도 |
GB2295387A (en) | 1994-11-23 | 1996-05-29 | Glaxo Inc | Quinazoline antagonists of alpha 1c adrenergic receptors |
GB9424233D0 (en) | 1994-11-30 | 1995-01-18 | Zeneca Ltd | Quinazoline derivatives |
US6046206A (en) * | 1995-06-07 | 2000-04-04 | Cell Pathways, Inc. | Method of treating a patient having a precancerous lesions with amide quinazoline derivatives |
GB9514265D0 (en) | 1995-07-13 | 1995-09-13 | Wellcome Found | Hetrocyclic compounds |
GB9607729D0 (en) * | 1996-04-13 | 1996-06-19 | Zeneca Ltd | Quinazoline derivatives |
DE69716916T2 (de) | 1996-07-13 | 2003-07-03 | Glaxo Group Ltd | Kondensierte heterozyklische verbindungen als protein kinase inhibitoren |
GB9718972D0 (en) * | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
EP0837063A1 (de) * | 1996-10-17 | 1998-04-22 | Pfizer Inc. | 4-Aminoquinazolinderivate |
AR012634A1 (es) | 1997-05-02 | 2000-11-08 | Sugen Inc | Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion |
TW436485B (en) | 1997-08-01 | 2001-05-28 | American Cyanamid Co | Substituted quinazoline derivatives |
EA004436B1 (ru) | 1998-09-29 | 2004-04-29 | Уайт Холдингз Корпорейшн | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ |
WO2000021955A1 (en) | 1998-10-08 | 2000-04-20 | Astrazeneca Ab | Quinazoline derivatives |
PT1154774E (pt) * | 1999-02-10 | 2005-10-31 | Astrazeneca Ab | Derivados de quinazolina como inibidores de angiogenese |
KR20020032608A (ko) * | 1999-09-21 | 2002-05-03 | 다비드 에 질레스 | 퀴나졸린 화합물 및 이를 함유하는 제약 조성물 |
ES2267748T3 (es) | 2000-04-07 | 2007-03-16 | Astrazeneca Ab | Compuestos de quinazolina. |
UA73993C2 (uk) | 2000-06-06 | 2005-10-17 | Астразенека Аб | Хіназолінові похідні для лікування пухлин та фармацевтична композиція |
KR100821446B1 (ko) * | 2000-08-21 | 2008-04-10 | 아스트라제네카 아베 | 퀴나졸린 유도체 |
JP2004511479A (ja) | 2000-10-13 | 2004-04-15 | アストラゼネカ アクチボラグ | キナゾリン誘導体 |
US6939866B2 (en) | 2000-10-13 | 2005-09-06 | Astrazeneca Ab | Quinazoline derivatives |
JP2004512335A (ja) | 2000-10-25 | 2004-04-22 | アストラゼネカ アクチボラグ | キナゾリン誘導体 |
ES2312557T3 (es) | 2001-04-19 | 2009-03-01 | Astrazeneca Ab | Derivados de quinazolina. |
WO2002092577A1 (en) | 2001-05-14 | 2002-11-21 | Astrazeneca Ab | Quinazoline derivatives |
WO2002092579A1 (en) | 2001-05-14 | 2002-11-21 | Astrazeneca Ab | 4-anilinoquinazoline derivatives |
WO2002092578A1 (en) | 2001-05-14 | 2002-11-21 | Astrazeneca Ab | Quinazoline derivatives |
DE60215178T2 (de) | 2001-07-16 | 2007-08-23 | Astrazeneca Ab | Quinolin-derivate und ihre verwendung als inhibitoren der tyrosine kinase |
-
2002
- 2002-04-15 ES ES02718343T patent/ES2312557T3/es not_active Expired - Lifetime
- 2002-04-15 US US10/475,016 patent/US7141577B2/en not_active Expired - Fee Related
- 2002-04-15 EP EP02718343A patent/EP1381599B1/de not_active Expired - Lifetime
- 2002-04-15 WO PCT/GB2002/001734 patent/WO2002085895A1/en active IP Right Grant
- 2002-04-15 DE DE60229046T patent/DE60229046D1/de not_active Expired - Lifetime
- 2002-04-15 AT AT02718343T patent/ATE409185T1/de not_active IP Right Cessation
- 2002-04-15 JP JP2002583422A patent/JP4307843B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2002085895A1 (en) | 2002-10-31 |
US7141577B2 (en) | 2006-11-28 |
JP2004525984A (ja) | 2004-08-26 |
EP1381599B1 (de) | 2008-09-24 |
JP4307843B2 (ja) | 2009-08-05 |
ES2312557T3 (es) | 2009-03-01 |
US20040138240A1 (en) | 2004-07-15 |
EP1381599A1 (de) | 2004-01-21 |
ATE409185T1 (de) | 2008-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE409185T1 (de) | Chinazolin derivate | |
NO20025792D0 (no) | Kinazolinderivater for behandling av tumorer | |
MY129809A (en) | Quinazoline derivatives | |
HK1063185A1 (en) | Quinoline derivatives and their use as tyrosine kinase inhibitors | |
ATE353888T1 (de) | Chinazolinderivate | |
IS6658A (is) | Ný efnasambönd | |
SE0104251D0 (sv) | Novel compounds | |
PT1263724E (pt) | Novos compostos | |
ATE293995T1 (de) | Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten | |
TW200624431A (en) | Phthalazinone derivatives, their manufacture and use as pharmaceutical agents | |
HK1057752A1 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
DE60116761D1 (en) | Adamantanderivate | |
SE0302139D0 (sv) | Novel compounds | |
DE60001586D1 (de) | Diphenyl-piperidin derivate | |
CY1107231T1 (el) | Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης | |
WO2003053960A3 (en) | Quinline derivates and their use as mek inhibitors | |
ATE429230T1 (de) | Chinazoline derivative und ihre anwendung in der krebsbehandlung | |
TW200420567A (en) | Quinazoline derivatives | |
SE0202693D0 (sv) | Compounds | |
SE0202692D0 (sv) | Compounds | |
TW200602329A (en) | Novel diazine derivatives, their manufacture and use as pharmaceutical agents | |
TW200505913A (en) | Novel oxazole derivatives, their manufacture and use as pharmaceutical agents | |
MXPA05011671A (es) | Nuevos derivados de anilina, su manufactura y su uso como agentes farmaceuticos. | |
TW200626590A (en) | Triazole derivatives, their manufacture and use as pharmaceutical agents | |
TH78316B (th) | อนุพันธ์ควินาโซลีน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |